AMNEAL PHARMACEUTICALS, INC. (AMRX) vs Regencell Bioscience Holdings Limited (RGC)
- AMNEAL PHARMACEUTICALS, INC. AMRX 19.18 −0.36%
- Regencell Bioscience Holdings Limited RGC 9.59 +0.74%
AMNEAL PHARMACEUTICALS, INC. and Regencell Bioscience Holdings Limited are both Drug Manufacturers Specialty & Generic companies. AMNEAL PHARMACEUTICALS, INC. is the larger, with a market value of $6.2B against $4.7B — 1.3× the size. Regencell Bioscience Holdings Limited has negative trailing earnings, so its P/E is not meaningful; AMNEAL PHARMACEUTICALS, INC. trades at 38.4×. AMNEAL PHARMACEUTICALS, INC. has the higher net margin (5.05% vs 0.00%) and the higher return on invested capital (11.1% vs 0.00%). Across the 13 metrics below, Regencell Bioscience Holdings Limited leads on 7 and AMNEAL PHARMACEUTICALS, INC. on 6.
Valuation
Profitability
| Metric | AMRX | RGC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 39.32% | — | 53.94% |
| Operating margin | 14.56% | — | 0.00% |
| Net margin | 5.05% | 0.00% | 0.00% |
| Free cash flow margin | (0.37%) | 0.00% | 0.00% |
| Return on equity | (395.84%) | 0.00% | (0.40%) |
| Return on assets | 4.37% | 0.00% | (3.32%) |
| Return on invested capital | 11.05% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack